Data / Form D filings / Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc.: Form D filings
Eureka Therapeutics, Inc., a biotechnology company in Emeryville, CA, filed 6 Form D notices with the SEC between 2014 and 2023. The latest, on May 17, 2023, reports an offering of $20 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5858 HORTON ST STE 370, Emeryville, CA, 94608
- Phone
- (510) 654-7045
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1386560
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 17, 2023 | New notice | $20,000,000 | $0 | $20,000,000 | 0 | Yet to occur | sec.gov |
| Jan 24, 2020 | New notice | $45,000,000 | $45,000,000 | 20 | Dec 16, 2019 | sec.gov | |
| Jun 18, 2018 | New notice | $20,000,000 | $20,000,000 | 2 | Jun 4, 2018 | sec.gov | |
| May 30, 2017 | Amendment | $60,000,000 | $26,572,831 | $33,427,169 | 40 | Dec 13, 2016 | sec.gov |
| Dec 12, 2016 | New notice | $40,000,000 | $0 | $40,000,000 | 0 | Yet to occur | sec.gov |
| Sep 22, 2014 | New notice | $21,000,000 | $21,000,000 | 28 | Aug 20, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Vivien S. Chan | Executive Officer | |
| Cheng Liu | Executive Officer, Director | |
| Michael Cannon | Director | |
| Marvin Samson | Director | |
| William S. Solari III | Director | |
| "Wai-Yan ""Sandy""" Chau | Director | |
| Reed Jobs | Director | |
| Victor S. Shum | Executive Officer | |
| Jacqueline Northcut | Director | |
| "Chih-Kai ""C.K." Cheng | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of May 15, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Eureka Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.